| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $249.7M | +6.7% | +17.9% |
| Cost of Revenue | $185.7M | +4.8% | +21.4% |
| Gross Profit | $64.0M | +12.6% | +8.8% |
| R&D Expense | $1.3M | -10.8% | -29.3% |
| SG&A Expense | $20.2M | +2.0% | -12.2% |
| Operating Income | $40.4M | +14.5% | +13.3% |
| Pre-tax Income | $20.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $79.6M | -10.1% | -9.7% |
| Accounts Receivable | $150.1M | -2.7% | -2.0% |
| Inventory | $44.6M | -0.7% | -5.9% |
| Current Assets | $504.7M | -0.8% | -6.1% |
| Total Assets | $6.09B | +1.3% | +9.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $230.1M | — | — |
| Capital Expenditures | $474.7M | — | — |
| Investing Cash Flow | -$579.8M | — | — |
| Financing Cash Flow | $349.1M | — | — |
| Free Cash Flow | -$244.6M | — | — |
| -9.1% |
| -19.3% |
| Income Tax | -$4.3M | +21.6% | -259.0% |
| Net Income | $24.1M | -13.9% | +9.3% |
| EPS (Basic) | $0.40 | -13.0% | +8.1% |
| EPS (Diluted) | $0.39 | -15.2% | +8.3% |
| $654.8M |
| -10.4% |
| +15.6% |
| Total Liabilities | $3.44B | +1.6% | +12.2% |
| Stockholders' Equity | $2.51B | +0.7% | +5.1% |